These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 16400299)

  • 21. Treatment of Parkinson's disease. Advances in the pharmacological therapy.
    Ghika J
    Eur Neurol; 1996; 36(6):396-9. PubMed ID: 8954312
    [No Abstract]   [Full Text] [Related]  

  • 22. Progress in Parkinson's disease.
    Schapira AH
    Eur J Neurol; 2008 Jan; 15(1):1. PubMed ID: 18171385
    [No Abstract]   [Full Text] [Related]  

  • 23. Visualizing vesicular dopamine dynamics in Parkinson's disease.
    de la Fuente-Fernández R; Sossi V; McCormick S; Schulzer M; Ruth TJ; Stoessl AJ
    Synapse; 2009 Aug; 63(8):713-6. PubMed ID: 19391152
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expectation and dopamine release: mechanism of the placebo effect in Parkinson's disease.
    de la Fuente-Fernández R; Ruth TJ; Sossi V; Schulzer M; Calne DB; Stoessl AJ
    Science; 2001 Aug; 293(5532):1164-6. PubMed ID: 11498597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Dopamine-receptor stimulants in the treatment of Parkinson's disease (author's transl)].
    Ringwald E; Hirt D; Markstein R; Vigouret JM
    Nervenarzt; 1982 Feb; 53(2):67-71. PubMed ID: 7063089
    [No Abstract]   [Full Text] [Related]  

  • 26. Parkinson's disease.
    Clarke C; Moore AP
    Clin Evid; 2002 Jun; (7):1208-20. PubMed ID: 12230738
    [No Abstract]   [Full Text] [Related]  

  • 27. Levodopa for the treatment of Parkinson's disease.
    Lewitt PA
    N Engl J Med; 2008 Dec; 359(23):2468-76. PubMed ID: 19052127
    [No Abstract]   [Full Text] [Related]  

  • 28. [Dopamine dysregulation syndrome in a patient with Parkinson's disease; a case report].
    Hol WM; van der Zwaard R; Hovestadt A; van Megen HJ
    Tijdschr Psychiatr; 2010; 52(4):259-63. PubMed ID: 20503167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Diagnosis and therapy of Parkinson's disease].
    Wittstock M; Benecke R
    MMW Fortschr Med; 2005 May; 147 Spec No 2():28-31. PubMed ID: 15968869
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Parkinson's disease.
    Clarke C; Moore A
    Clin Evid; 2002 Dec; (8):1370-85. PubMed ID: 12603943
    [No Abstract]   [Full Text] [Related]  

  • 31. Second International Symposium on the Treatment of Parkinson's Disease.
    Mizuno Y
    Neurology; 1998 Aug; 51(2 Suppl 2):S1. PubMed ID: 9711972
    [No Abstract]   [Full Text] [Related]  

  • 32. Reevaluation of levodopa therapy for the treatment of advanced Parkinson's disease.
    Yokochi M
    Parkinsonism Relat Disord; 2009 Jan; 15 Suppl 1():S25-30. PubMed ID: 19131038
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of new pharmacological approaches in Parkinson's disease.
    Carlsson A
    Adv Neurol; 1987; 45():513-8. PubMed ID: 3493631
    [No Abstract]   [Full Text] [Related]  

  • 34. Glutamate measurement in Parkinson's disease using MRS at 3 T field strength.
    Kickler N; Krack P; Fraix V; Lebas JF; Lamalle L; Durif F; Krainik A; Rémy C; Segebarth C; Pollak P
    NMR Biomed; 2007 Dec; 20(8):757-62. PubMed ID: 17334978
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Current strategies for the treatment of Parkinson's disease].
    Wolters A; Benecke R
    MMW Fortschr Med; 2012 Apr; 154(7):59-62. PubMed ID: 22558877
    [No Abstract]   [Full Text] [Related]  

  • 36. Parkinson's disease: new approaches to diagnosis and treatment.
    Yahr MD
    Acta Neurol Scand Suppl; 1993; 146():22-5. PubMed ID: 8333251
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Objective assessment in Parkinson's disease: optoelectronic movement and force analysis in clinical routine and research.
    Ingvarsson PE; Johnels B; Steg G; Olsson T
    Adv Neurol; 1999; 80():447-58. PubMed ID: 10410755
    [No Abstract]   [Full Text] [Related]  

  • 38. Early therapy for Parkinson's disease.
    Olanow CW
    Eur Neurol; 1992; 32 Suppl 1():30-5. PubMed ID: 1358615
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synaptic plasticity, dopamine and Parkinson's disease: one step ahead.
    Calabresi P; Mercuri NB; Di Filippo M
    Brain; 2009 Feb; 132(Pt 2):285-7. PubMed ID: 19168452
    [No Abstract]   [Full Text] [Related]  

  • 40. [Mechanism of the development of akinesia in Parkinson's disease --with reference to L-threo-DOPS therapy].
    Narabayashi H
    No To Shinkei; 1983 Nov; 35(11):1057-63. PubMed ID: 6362685
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.